GW Pharmaceuticals PLC (NASDAQ:GWPH)

125.63
Delayed Data
As of 4:00pm ET
 -0.32 / -0.25%
Today’s Change
67.98
Today|||52-Week Range
180.75
+20.15%
Year-to-Date
Is GW Pharmaceuticals Stock a Buy?
Jun 30 / MotleyFool.com - Paid Partner Content
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Jun 28 / MotleyFool.com - Paid Partner Content
Where Will GW Pharmaceuticals Be in 1 Year?
Jun 29 / MotleyFool.com - Paid Partner Content
2 Ways the Cannabis Industry Is Shooting Itself in the Foot
Jun 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close125.95
Today’s open127.90
Day’s range124.81 - 127.90
Volume9,819
Average volume (3 months)469,339
Market cap$3.7B
Data as of 4:00pm ET, 07/02/2020

Growth & Valuation

Earnings growth (last year)+96.96%
Earnings growth (this year)-602.05%
Earnings growth (next 5 years)+42.59%
Revenue growth (last year)+1,918.66%
P/E ratio104.7
Price/Sales10.36
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+2.17+2.13%
----
CCXIChemoCentryx Inc-0.22-0.38%
FOLDAmicus Therapeutics ...-0.01-0.06%
Data as of 4:00pm ET, 07/02/2020

Financials

Next reporting dateAugust 11, 2020
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$312.6M
Annual profit (last year)-$9.1M
Net profit margin-2.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts